Skip to main content

Day: September 5, 2025

24/7 Market News: Everything’s Bigger in Texas… Especially the Sunset Amphitheaters (NYSE: VENU)

DENVER, Sept. 05, 2025 (GLOBE NEWSWIRE) — 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, confirms that VENU (NYSE American: VENU), a trailblazer in premium hospitality and live entertainment, officially broke ground on its $300 million Sunset Amphitheater on June 13, 2025, in McKinney, Texas. According to Founder, Chairman, and CEO J.W. Roth, the Sunset VENU will be “the most luxurious fully seated, multi-configuration, all-season venue in history.” The amphitheater will feature a canopied roof, wind walls, LuxeFire Suites, and a members-only Aikman Club, in collaboration with NFL Hall of Fame quarterback Troy Aikman, Founder of EIGHT Elite Light Beer. Nestled at the center of the amphitheater, the Aikman Club offers one-of-a-kind views, premium...

Continue reading

Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation (“TMS”) clinics, and Advanced Behavioral Strategies (ABS). The collaboration comes on the heels of HealingMaps and Capstone Management Group announcing their official launch of the Healing Health Alliance*, the first-of-its-kind Group Purchasing Organization (“GPO”) dedicated to supporting ketamine clinics, psilocybin retreats, TMS clinics, and more. It will provide HealingMaps’ large and growing provider...

Continue reading

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress. “This fiscal year has been transformative for iBio as we advanced both our pipeline and corporate strategy,” said Martin Brenner, Ph.D., DVM, Chief Executive Officer and Chief Scientific Officer of iBio. “We began building a differentiated preclinical portfolio in cardiometabolic diseases and obesity, highlighted by IBIO-610, an activin E-targeting antibody with compelling preclinical data supporting high-quality fat loss with muscle preservation, and IBIO-600, our long-acting anti-myostatin antibody. In parallel, we unveiled an additional innovative program, a bispecific antibody...

Continue reading

K Wave Media Subsidiary Solaire Partners Selected to Manage $28 Million IPTV Fund, Signaling New Era for K-Content Market

The venture capital firm behind ‘Parasite’ and ‘Spring of Seoul’ will manage a joint fund backed by Korea’s three leading IPTV operators, aiming to finance 3–4 major films each year. NEW YORK and SEOUL, South Korea, Sept. 05, 2025 (GLOBE NEWSWIRE) — Solaire Partners, a subsidiary of K Wave Media (NASDAQ: KWM) and the venture capital firm known for investing in acclaimed films ‘Parasite’ and ‘12.12: The Day’, has been selected as the general partner (GP) to manage a KRW 40 billion (~USD $28 million) fund jointly financed by Korea’s three major IPTV operators—KT, SK Broadband, and LG Uplus. The fund formation represents a strategic initiative to revitalize the IPTV VOD (Video on Demand) market, which has faced challenges from the rapid growth of OTT platforms, and to establish a sustainable ecosystem...

Continue reading

Final terms for bonds to be listed 10th September 2025

To Nasdaq Copenhagen A/S                        5th September 2025                                        Announcement no. 75/2025 Final terms for bonds to be listed 10th September 2025 On 10th February 2025, Jyske Realkredit A/S will be listing a new Covered Bond (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 27th, 2025. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours sincerely,Jyske Realkredit A/S www.jyskerealkredit.com Please...

Continue reading

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~ ~ All patients in first cohort discontinued enzyme replacement therapy ~ ~ Preliminary data show AMT-191 has a manageable safety profile at the highest dose ~ ~ Updated clinical results expected in the first half of 2026 ~ LEXINGTON, Mass. and AMSTERDAM, Sept. 05, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced initial safety and exploratory efficacy data from the first cohort of its Phase I/IIa trial of AMT-191, an investigational gene therapy for the treatment of Fabry disease. The preliminary data were presented at the International Congress of Inborn Errors of Metabolism...

Continue reading

Bunker Hill Announces C$45 Million “Bought Deal” Private Placement of Units

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / KELLOGG, Idaho and VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR |OTCQB: BHLL) is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”), as lead underwriter and sole bookrunner, on its own behalf and on behalf of a syndicate of underwriters (together with Haywood, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a “bought deal” private placement basis, 375,000,000 units of the Company (the “Units”) at a price per Unit of C$0.12 (the “Issue Price”) for aggregate gross proceeds to the Company of C$45,000,000 (the “Offering”). Each Unit will consist of one...

Continue reading

Bunker Hill Announces C$45 Million “Bought Deal” Private Placement of Units

KELLOGG, Idaho and VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (“Bunker Hill” or the “Company”) (TSX-V: BNKR |OTCQB: BHLL) is pleased to announce that it has entered into an agreement with a lead underwriter, acting on behalf of a syndicate of underwriters (the “Underwriters”) to be formed, under which the Underwriters have agreed to purchase, on a “bought deal” private placement basis, 375,000,000 units of the Company (the “Units”) at a price per Unit of C$0.12 (the “Issue Price”) for aggregate gross proceeds to the Company of C$45,000,000 (the “Offering”). Each Unit will consist of one share of common stock of the Company (a “Common Share”) and one common stock purchase warrant of the Company (a “Warrant”). Each Warrant will entitle the holder thereof to acquire one share...

Continue reading

ABM Reports Fiscal Third Quarter 2025 Results and Comments on Fiscal 2025 Outlook

Revenue up 6.2% to $2.2 billion, including organic growth of 5.0% Net income of $41.8 million and earnings per diluted share of $0.67, versus $4.7 million and $0.07 in the prior year, respectively Adjusted net income of $51.7 million and adjusted earnings per diluted share of $0.82, versus $53.6 million, or $0.84 in the prior year, respectively Adjusted EBITDA up 5% to $125.8 million Operating cash flow up 120.1% to $175.0 million and free cash flow up 134.3% to $150.2 million Board approves a $150 million increase in share repurchase authorizationNEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering and infrastructure solutions, today announced financial results for its fiscal third quarter ended July 31, 2025. “ABM’s third quarter performance was highlighted by mid-single-digit...

Continue reading

Wrap Technologies and STORM Training Group Partner to Deliver Post-BolaWrap® Arrest & Control Training via WrapTactics™

Joint digital and instructor-led subscription ecosystem expected to enhance defensive tactics, lawful control, and officer safety by bridging training gaps after BolaWrap® deployment MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (the “Company” or “Wrap”), a leader in pre-escalation and public safety solutions, today announced a strategic partnership with STORM Training Group, a Minnesota-based provider of evidence-based defensive tactics and use-of-force training for law enforcement and security agencies.This collaboration is intended to enable agencies to pair BolaWrap® deployment with proven follow-up techniques that reduce officer risk during hand-to-hand encounters. STORM’s on-point instruction, drawn from decades of experience in defensive tactics and arrest procedures, will be made accessible...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.